Sana Biotechnology (SANA) Treasury Shares (2020 - 2026)
Sana Biotechnology (SANA) posted Treasury Shares of $5.1 million for Q1 2026, up 33.59% sequentially from $3.8 million in Q4 2025, and up 14.66% YoY from $4.5 million in Q1 2025.
Sana Biotechnology (SANA) Treasury Shares (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Treasury Shares for 7 years, with the latest figure at $5.1 million in Q1 2026.
- Quarterly Treasury Shares rose 14.66% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 14.66% YoY) and the FY2025 annual result came in at $3.8 million, up 7.23% from the prior year.
- Treasury Shares rose to $5.1 million in Q1 2026 per SANA's latest filing, from $3.8 million in the prior quarter.
- Over five years, Treasury Shares peaked at $5.1 million in Q1 2026 and troughed at $806000.0 in Q3 2022.
- A 5-year average of $3.0 million and a median of $3.5 million in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares slumped 86.1% in 2022, then jumped 167.52% in 2024.
- Over 5 years, Treasury Shares stood at $885000.0 in 2022, then surged by 164.52% to $2.3 million in 2023, then soared by 52.5% to $3.6 million in 2024, then rose by 7.23% to $3.8 million in 2025, then jumped by 33.59% to $5.1 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $5.1 million, $3.8 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | 4.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.76 Mn |
| Jun 30, 2026 | 4.76 Mn |
| Mar 31, 2026 | 5.11 Mn |
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Mar 31, 2024 | 4.23 Mn |